Gastrointestinal Cancer

Explore the latest updates, including expert interviews and features
Latest videos VJSessions Subtypes Topics Conferences Features Editorial Board

Welcome to the Gastrointestinal Cancer Channel!

Catch up on the latest developments in gastrointestinal cancer with VJOncology, featuring exclusive interviews, podcasts, and expert-led roundtable discussions.

Subtypes

Gastric Cancer
Colorectal Cancer
Liver Cancer
Bile Duct Cancer
Pancreatic Cancer
0:48
Current and future directions in gastric cancer research
Zev Wainberg • 12 Apr 2022
0:57
Combined inhibition of PARP and VEGF in gastric cancer
Michael Cecchini • 11 Apr 2022
3:18
Immune checkpoint inhibitors and combination strategies for patients with gastric cancer
Sun Young Rha • 25 Jan 2022
3:16
HER-RAM: investigating trastuzumab, ramucirumab and paclitaxel for the second-line treatment of GC
Sun Young Rha • 25 Jan 2022
View All Videos
1:42
Effect of microbes on clinical outcomes of neoadjuvant treatment in patients with rectal cancer
Francisco Sanchez-Vega • 10 Apr 2022
4:05
Racial disparities in clinical outcomes for patients with colorectal cancer
Francisco Sanchez-Vega • 10 Apr 2022
1:52
Effect of chemokine-modulating infusion on local infiltration of immune cells into colorectal tumors
Pawel Kalinski • 12 Apr 2022
2:28
Unmet needs for early onset colorectal cancer
Elisa Fontana • 25 Mar 2022
View All Videos
4:56
HIMALAYA: tremelimumab + durvalumab in unresectable HCC
Richard D. Kim • 27 Jan 2022
2:53
RENOBATE: investigating regorafenib plus nivolumab as 1st-line therapy for unresectable HCC
Changhoon Yoo • 25 Jan 2022
4:56
HIMALAYA: tremelimumab + durvalumab in unresectable HCC
Richard D. Kim • 27 Jan 2022
1:30
CAMILLA: Combining a VEGF TKI with immune checkpoint inhibitors for GE and GI cancer
Anwaar Saeed • 13 Nov 2021
View All Videos
8:18
The use of ctDNA in patient cancer care
Arvind Dasari • 1 Feb 2022
1:31
Highlights and key clinical trial updates from ASCO GI 2022
Melissa Lumish • 24 Jan 2022
3:17
TOPAZ-1: the addition of durvalumab to chemotherpay for the treatment of BTC in the 1st-line setting
Richard D. Kim • 27 Jan 2022
0:56
Key updates at ASCO GI 2022
Afsaneh Barzi • 17 Jan 2022
View All Videos
1:49
The challenges in implementing CAR-T cell therapy for the treatment of solid tumors
Richard D. Kim • 27 Jan 2022
6:17
PCRT16-001: can PEGPH2O remodel the stroma to sensitize patients with HA-high PC to immunotherapy?
David Bing Zhen • 27 Jan 2022
1:44
Improving responses to immunotherapy in metastatic pancreatic cancer
David Bing Zhen • 27 Jan 2022
3:43
PREVAIL: investigating ctDNA for the diagnosis of pancreatic and biliary duct cancer
Justin Mencel • 24 Jan 2022
View All Videos

Topics

Immuno-Oncology
CAR-T & Cellular Therapy
Trial Updates
Molecular Profiling
Radiotherapy
1:52
Effect of chemokine-modulating infusion on local infiltration of immune cells into colorectal tumors
Pawel Kalinski • 12 Apr 2022
0:48
Current and future directions in gastric cancer research
Zev Wainberg • 12 Apr 2022
0:57
Combined inhibition of PARP and VEGF in gastric cancer
Michael Cecchini • 11 Apr 2022
3:01
Treating patients with gastric cancer with immunotherapy: who will benefit?
Sun Young Rha • 25 Jan 2022
View All Videos
3:05
RTX-240: allogeneic RBCs drive expansion & trafficking of CD8+ T-cells & NK cells into the TME
Omid Hamid • 11 Apr 2022
3:18
Immune checkpoint inhibitors and combination strategies for patients with gastric cancer
Sun Young Rha • 25 Jan 2022
1:49
The challenges in implementing CAR-T cell therapy for the treatment of solid tumors
Richard D. Kim • 27 Jan 2022
2:50
CAR-T cells versus SPEAR T-cells to treat solid tumors
David S. Hong • 24 Jan 2022
View All Videos
1:52
Effect of chemokine-modulating infusion on local infiltration of immune cells into colorectal tumors
Pawel Kalinski • 12 Apr 2022
3:08
INVICTUS: long-term results for ripritnanib as 4th-line therapy in advanced GIST
Robin Jones • 13 Apr 2022
1:57
INVICTUS and INTRIGUE: investigating ripretinib in patients with advanced GIST
Robin Jones • 13 Apr 2022
3:05
RTX-240: allogeneic RBCs drive expansion & trafficking of CD8+ T-cells & NK cells into the TME
Omid Hamid • 11 Apr 2022
View All Videos
1:42
Effect of microbes on clinical outcomes of neoadjuvant treatment in patients with rectal cancer
Francisco Sanchez-Vega • 10 Apr 2022
4:05
Racial disparities in clinical outcomes for patients with colorectal cancer
Francisco Sanchez-Vega • 10 Apr 2022
1:19
The importance of studying circulating tumor cell lines
Catherine Alix-Panabieres • 12 Apr 2022
2:28
Unmet needs for early onset colorectal cancer
Elisa Fontana • 25 Mar 2022
View All Videos
2:24
The remaining challenges surrounding the use of immunotherapy to treat patients with rectal cancer
Melissa Lumish • 24 Jan 2022
2:07
Unanswered questions on the use of immunotherapy in CRC
Susanna Varkey • 28 Jan 2022
6:56
Prior RT may potentially enhance treatment of MSS-CRC with regorafenib and pembrolizumab
Afsaneh Barzi • 17 Jan 2022
2:15
Averectal: short-course radiation plus chemotherapy in addition to chemo-IO, followed by surgery
Ali Shamseddine • 12 Jan 2022
View All Videos

Conferences

ESMO 2021
ESMO WCGIC 2021
ASCO 2021
AACR 2021
ASCO GI 2021
3:01
Genomic landscape of late-stage gastric cancer treated with pembrolizumab
Yelena Y. Janjigian • 28 Sep 2021
3:41
Highlights in gastric cancer from ESMO 2021
Yelena Y. Janjigian • 28 Sep 2021
2:39
DESTINY-Gastric02: 2L T-DXd in HER2+ gastric cancers
Geoffrey Ku • 27 Sep 2021
2:04
Update on the CheckMate649 trial in treatment-naïve GEA
Elizabeth C. Smyth • 21 Sep 2021
View All Videos
2:58
Tislelizumab in patients with unresectable HCC demonstrates durable responses
Ghassan Abou-Alfa • 25 Jun 2021
2:35
Impact of timing of perioperative chemotherapy on OS in patients with CRC liver metastases
Firas Baidoun • 7 Jul 2021
1:37
Impact of gender and HPV status on anal squamous cell carcinoma survival
Firas Baidoun • 7 Jul 2021
0:40
1L NALIRIFOX in advanced or metastatic PDAC
Zev Wainberg • 1 Jul 2021
View All Videos
1:55
AVANA: preoperative chemo-RT plus avelumab in locally advanced rectal cancer
Lisa Salvatore • 11 Jun 2021
4:24
NIFTY: liposomal irinotecan in combination with 5FU and leucovorin in patients with mBTC
Changhoon Yoo • 15 Jun 2021
1:56
Improving outcomes in HCC with immunotherapy
Arndt Vogel • 11 Jun 2021
4:59
CheckMate 648: 1L IO-IO in advanced esophageal squamous cell carcinoma
Ian Chau • 15 Jun 2021
View All Videos
3:05
IMbrave150: updated data on atezo plus bev versus sorafenib in HCC
Peter R. Galle • 20 Apr 2021
2:25
Using oncolytic viruses in solid tumors
Kaidre Bendjama • 15 Apr 2021
4:35
TG6002, an oncolytic virus induces expression of a pro-drug activating enzyme in advanced GI cancers
Kaidre Bendjama • 15 Apr 2021
11:49
Racial differences in somatic mutations among patients with early-onset CRC
Andreana N. Holowatyj • 9 Apr 2021
View All Videos
2:21
Updates in the use of neratinib in fibrolamellar carcinoma and biliary tract cancer
Ghassan Abou-Alfa • 21 Jan 2021
3:02
ASCO GI: IO and interventional oncology
Thomas Helmberger • 22 Jan 2021
4:32
First-line regorafenib 80mg/day with pembrolizumab in advanced HCC
Anthony B. El-Khoueiry • 20 Jan 2021
3:05
Alliance A021501: preoperative mFOLFIRINOX +/- hypofractionated RT for pancreatic cancer
Joshua E. Meyer • 20 Jan 2021
View All Videos
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals